2-(3,4-dichloro-5-methyl-1H-pyrrole-2-carboxamido)benzo[d]thiazole-6-carboxylic acid

ID: ALA4873935

PubChem CID: 150278089

Max Phase: Preclinical

Molecular Formula: C14H9Cl2N3O3S

Molecular Weight: 370.22

Molecule Type: Unknown

Names and Identifiers

Canonical SMILES:  Cc1[nH]c(C(=O)Nc2nc3ccc(C(=O)O)cc3s2)c(Cl)c1Cl

Standard InChI:  InChI=1S/C14H9Cl2N3O3S/c1-5-9(15)10(16)11(17-5)12(20)19-14-18-7-3-2-6(13(21)22)4-8(7)23-14/h2-4,17H,1H3,(H,21,22)(H,18,19,20)

Standard InChI Key:  GEZPDKBNSBNCLH-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 23 25  0  0  0  0  0  0  0  0999 V2000
    7.2513  -27.9027    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.9609  -27.4933    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.9581  -26.6706    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2495  -26.2654    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.5432  -27.4938    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.5444  -26.6727    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7639  -26.4178    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    5.2803  -27.0814    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7620  -27.7463    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.4660  -27.0802    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.0584  -26.3720    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2412  -26.3708    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4680  -25.6648    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.7620  -25.7052    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.9844  -25.9567    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9833  -26.7739    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7601  -27.0274    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3210  -27.2563    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    8.6643  -26.2594    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.3735  -26.6653    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.6612  -25.4422    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.0101  -27.8070    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    1.3239  -25.4754    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  5  1  1  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  6  1  0
  5  6  2  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  9  5  1  0
  8 10  1  0
 10 11  1  0
 11 12  1  0
 11 13  2  0
 12 14  1  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 12  2  0
 16 18  1  0
  3 19  1  0
 19 20  1  0
 19 21  2  0
 17 22  1  0
 15 23  1  0
M  END

Alternative Forms

1. Parent:

   

   ALA4873935

   ---

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Unknown

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 370.22

Molecular Weight (Monoisotopic): 368.9742

AlogP: 4.19

#Rotatable Bonds: 3

Polar Surface Area: 95.08

Molecular Species: ACID

HBA: 4

HBD: 3

#RO5 Violations: ┄

HBA (Lipinski): 6

HBD (Lipinski): 3

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: 3.62

CX Basic pKa: ┄

CX LogP: 3.95

CX LogD: 0.62

Aromatic Rings: 3

Heavy Atoms: 23

QED Weighted: 0.64

Np Likeness Score: -1.91

References

1. Durcik M, Nyerges Á, Skok Ž, Skledar DG, Trontelj J, Zidar N, Ilaš J, Zega A, Cruz CD, Tammela P, Welin M, Kimbung YR, Focht D, Benek O, Révész T, Draskovits G, Szili PÉ, Daruka L, Pál C, Kikelj D, Mašič LP, Tomašič T..  (2021)  New dual ATP-competitive inhibitors of bacterial DNA gyrase and topoisomerase IV active against ESKAPE pathogens.,  213  [PMID:33524686] [10.1016/j.ejmech.2021.113200]

Source

Source(1):

• Scientific Literature